StreetInsider.com News Articles

Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026

Mon, 19 Oct 2026 07:00:00 -0400

REHOVOT, Israel and HOBOKEN, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate in two investor conferences during the month of November.

Mr. London will attend the Stifel 2026 Healthcare Conference, to be held at the Lotte New York Palace Hotel, New York, NY on November 10-12, 2026, and is scheduled to present at 10:00 a.m. Eastern

Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026

Mon, 19 Oct 2026 07:00:00 -0400

Mr. London will attend the Stifel 2026 Healthcare Conference, to be held at the Lotte New York Palace Hotel, New York, NY on November 10-12, 2026, and is scheduled to present at 10:00 a.m. Eastern

Stifel Reiterates Buy Rating on Kamada Ltd. (KMDA)

Tue, 06 Oct 2026 10:14:11 -0400

Stifel analyst Annabel Samimy reiterated a Buy rating and $11.00 price target on Kamada Ltd. (NASDAQ: KMDA).

The analyst comments "Kamada today announced the launch of two additional biosimilars, Ustekinumab-Kamada (Stelara), a monoclonal antibody indicated for immune-mediated inflammatory diseases, and Enoxaparin-Kamada (Clexane), a low-molecular-weight heparin used to treat and prevent thromboembolic disorders. These products expand KMDA's existing biosimilar portfolio, which already includes Bevacizumab-Kamada (Avastin) and Pegfilgrastim-Kamada (Neulasta), bringing the total number of commercialized biosimilars to four, with at least two additional launches planned in 2027. KMDA's biosimilar business is expected to generate $4 million in annual sales for 2026, but management

Kamada launches two biosimilars in Israel, eyes $25M revenue by 2030

Tue, 06 Oct 2026 07:02:35 -0400

Kamada Ltd. (NASDAQ: KMDA) announced the commercial launch of two biosimilar products in Israel, expanding its biosimilar portfolio to four total products, according to a company press release.

The two newly launched products are Ustekinumab-Kamada, a biosimilar to Stelara used to treat chronic immune-mediated inflammatory diseases including plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis, and Enoxaparin-Kamada, a biosimilar to Clexane used for the prevention and treatment of thromboembolic disorders such as deep vein thrombosis and pulmonary embolism.

The new launches follow the earlier introduction of Bevacizumab-Kamada, a biosimilar to Avastin, and Pegfilgrastim-Kamada, a biosimilar to Neulasta, both launched in Israel

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

Tue, 06 Oct 2026 07:00:00 -0400

REHOVOT, Israel and HOBOKEN, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced the expansion of its biosimilar portfolio with the commercial launch of two additional new products in Israel, adding to its existing portfolio of two products.

The two newly launched biosimilar products are Ustekinumab-Kamada, a biosimilar to Stelara®, a monoclonal antibody indicated for the treatment of chronic immune-mediated inflammatory diseases, including plaque psoriasis,

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

Tue, 06 Oct 2026 07:00:00 -0400

Form 6-K KAMADA LTD For: Oct 06

Tue, 06 Oct 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20261006/27151685.html

Form 6-K KAMADA LTD For: Oct 05

Mon, 05 Oct 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20261005/27148561.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Asher-Topilsky Lilach

Tue, 29 Sep 2026 09:27:00 -0400

si-local-file:///var/storage/secattach/20260929/27118909.html

Form 4 KAMADA LTD For: Aug 27 Filed by: DAVIDI ISHAY

Tue, 29 Sep 2026 09:13:00 -0400

si-local-file:///var/storage/secattach/20260929/27118801.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Botzer Uri

Tue, 29 Sep 2026 09:08:00 -0400

si-local-file:///var/storage/secattach/20260929/27118718.html

Form 4 KAMADA LTD For: Aug 27 Filed by: London Amir

Fri, 25 Sep 2026 06:24:00 -0400

si-local-file:///var/storage/secattach/20260925/27103936.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Gorelik Boris

Thu, 24 Sep 2026 15:28:00 -0400

si-local-file:///var/storage/secattach/20260924/27101904.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Payorski Lilach

Thu, 24 Sep 2026 15:22:00 -0400

si-local-file:///var/storage/secattach/20260924/27101868.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Reshef Liron

Thu, 24 Sep 2026 15:20:00 -0400

si-local-file:///var/storage/secattach/20260924/27101851.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Goldwasser Karnit

Thu, 24 Sep 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260924/27098704.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Beladev Shavit

Thu, 24 Sep 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260924/27098705.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Livneh Nir

Wed, 23 Sep 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260923/27096731.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Pinchuk Orit

Wed, 23 Sep 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260923/27096662.html

Form 4 KAMADA LTD For: Aug 27 Filed by: RECANATI LEON

Wed, 23 Sep 2026 15:58:00 -0400

si-local-file:///var/storage/secattach/20260923/27096621.html

Form 4 KAMADA LTD For: Aug 27 Filed by: ORLEV CHAIME

Wed, 23 Sep 2026 15:53:00 -0400

si-local-file:///var/storage/secattach/20260923/27096586.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Nir Eran

Wed, 23 Sep 2026 13:32:00 -0400

si-local-file:///var/storage/secattach/20260923/27095935.html

Form 4 KAMADA LTD For: Aug 27 Filed by: ITSHAYEK ASSAF

Wed, 23 Sep 2026 13:02:00 -0400

si-local-file:///var/storage/secattach/20260923/27095821.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Dekel Benjamin

Wed, 23 Sep 2026 12:58:00 -0400

si-local-file:///var/storage/secattach/20260923/27095708.html

Form 4 KAMADA LTD For: Aug 27 Filed by: Neheman Hanni

Wed, 23 Sep 2026 12:54:00 -0400

si-local-file:///var/storage/secattach/20260923/27095698.html